LONDON (Reuters) - AstraZeneca's oncology business received a boost on Wednesday as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live longer without their disease worsening when given as a first-line treatment.
WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday blocked a California law requiring clinics that counsel women against abortion to notify clients of the availability of abortions paid for by the state, finding that it violated the free speech rights of these Christian-based facilities.
(Reuters Health) - - Women who get abortions at clinics or doctors' offices may be no more likely to experience serious complications than patients who have these procedures at surgery centers, a U.S. study suggests.
TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc will not make its experimental stem cell treatment for neurodegenerative diseases available under the new U.S. "Right to Try" (RTT) act, citing a failure to find a way to enable all patients to afford the treatment.
(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc's epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.
(Reuters) - The U.S. Food and Drug Administration cleared Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, but shares slumped 25 percent as the drug failed to win approval for treating bloodstream infections.
BEIJING/PARIS (Reuters) - China reported an outbreak of highly pathogenic H5N1 bird flu at a farm in its northwest Qinghai province, the Paris-based World Organisation for Animal Health (OIE) said on Tuesday, citing a report from the Chinese agriculture ministry.
The legalization of recreational marijuana in California this year was meant to bring the drug out of the dark and into the open. But half a year in, industry experts say surprisingly high taxes are giving some consumers sticker shock and sending them back to the black market.
Polar bears consume no more energy than similarly sized animals while walking, according to new research which counters previous scientific thinking. The findings are important because Arctic ice shrinkage is forcing the creatures to travel further distances to hunt seals. Jim Drury reports.
You might like...
Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.